Skip to content
MS
Single-pathway Pathway metabolite unreviewed

ApoB-48

0
Pathways
0
Categories
0
As substrate
0
As product

Reactions involving ApoB-48

Every recorded step where this molecule takes part

Showing all 1 reactions.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Oral self-assembly nanoemulsion drives <i>in vivo</i> hepatic stellate cell-targeting drug delivery in liver fibrosis.

    Shen X, Deng J, Jiang A, Cai Q, Tian D, Zhao L, Ye J, Zhang L, Xiang Y, Zhang Q. · 2026-06-12

    open access unreviewed
  2. 2
    Decoding the Gut–Fat–Heart Axis: From Molecular Communication Networks to Clinical Translation Strategies

    Sun Z, Shao W, Zhang H, Wang K, Liu Y, Zhou R. · 2026-06-01

    open access unreviewed
  3. 3
  4. 4
    Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials.

    Ballantyne CM, Baass A, Rosenson RS, Hegele RA, Nicholls SJ, Vasas S, Clifton P, Lucas KJ, Pall D, Zhou R, Le… · 2026-03-24

    cited 3× open access unreviewed
  5. 5
    From lipid overload to autophagy collapse: how lipid dysregulation drives chronic inflammation and metabolic disease.

    Fomin M, Zapf K, Schieffer E, Freitag J, Bange G, Schieffer B. · 2026-06-11

    open access unreviewed
  6. 6
    Context-Dependent Effects of Apolipoprotein A2 on Lipid Metabolism and Atherogenesis.

    Zvintzou E, Fenyo IM, Ionita R, Kakafoni G, Dumitrescu M, Alemi M, Daraban BS, Marinos K, Gafencu AV, Kypreos… · 2026-06-01

    open access unreviewed
  7. 7
    Century of Progress on the Structure of APOB-100 in Atherogenic Lipoproteins.

    Coleman B, Woollett LA, Davidson WS. · 2026-06-04

    cited 1× unreviewed
  8. 8
    GPR182 is a lipoprotein receptor for dietary fat absorption.

    Sun Z, Torphy RJ, Miller EN, Darehshouri A, Vigil I, Terai T, Eck E, Sun Y, Guo Y, Fykstra DP, Yee EJ, Hu J, … · 2026-03-24

    open access unreviewed
  9. 9
    Impaired glycosylation promotes rapid transition to hepatocellular carcinoma in model of diet-induced steatotic liver disease.

    Singh AK, Chaube B, Citrin KM, Fowler JW, Lee S, Catarino J, Knight J, Lowery SC, Shree S, Mahoney KE, Boutag… · 2026-03-10

    open access unreviewed
  10. 10
    The Past, Present, and Future of Dyslipidemia: A Narrative Review.

    Manoria PC. · 2026-04-01

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.